Issues: Vax Specific

Anthrax

Hepatitis B

Hib 

HPV

Influenza

Lyme Disease
Meningococcal

MMR    

Pneumococcal

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Religion

Thimerosal

 

Vaccine Info

2014 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

HEPATITIS B VACCINE

  • Hepatitis B vaccine in adults with diabetes.  Policy Note: Use of Hepatitis B Vaccine in Adults with Diabetes Mellitus MMWR 2011;60(50):1709. [link] (12-23-11)

  • Vaccine Information Statement on Hep B updated February 2 2012. link

  • IAC provides a table on Hepatitis B Prevention Mandates for Daycare and K-12 link

  • Position papers continue WHO’s recommendations for Hep B vaccine at birth and 2-3 follow-up doses.  
    WHO also comments on the excellent safety of Hep B vaccines. Wkly Epi Record 2009;84(40):405.
    Link

  • Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. 
    Jane Zuckerman's review article finds that there is no evidence of an association between hepatitis B vaccine and SIDS, MS or Chronic Fatigue Syndrome. Zuckerman also reports that Hepatitis B vaccines are among the safest vaccines with few true adverse reactions. J Med Virol 2006 Feb;78(2):169-77. PubMed Abstract

  • IOM Press Release: No Link Found Between Hepatitis B Vaccine and Certain Neurological Disorders. (05-30-02) Link
    IOM Report on Hepatitis B Vaccine and Demyelinating Neurological Disorders.  The Institute of Medicine's Immunization Safety Review Committee found that the epidemiologic evidence "favors rejection of a causal relationship between the hepatitis B vaccine in adults and multiple sclerosis". (05-30-02)
    Link

  • Balancing Risks and Benefits: Primum non nocere Is Too Simplistic.
    Neal Halsey and Lynn Goldman's response to an earlier commentary regarding the delay of the birth dose of hepatitis B vaccine.  They also include new information regarding methyl- and ethyl-mercury.  Pediatrics 2001 Aug;108(2):466-7. (08-02-01)
    Link to Pediatrics

  • Studies published in the New England Journal of Medicine confirm that hepatitis B vaccine does not increase risk of multiple sclerosis (02-01-01). More Info

  • Fears of Hepatitis Vaccine/Multiple Sclerosis Link Unfounded
    Flu and Tetanus Immunizations Also Safe for MS Patients: link to story on WebMD (1-31-01).

  • New Preservative-Free Hepatitis B Vaccine approved by FDA for pediatric and adolescent use (03-31-00). More Info

  • Transverse myelitis not a recognized vaccine complication
    Clarification of Dr. Kerr's position on hepatitis B vaccine and transverse myelitis (12-01-99).
    More Info

  • New Thimerosal-free Hepatitis B Vaccine for Use in Infants
    On August 27,1999, the FDA approved a modified hepatitis B vaccine (Recombivax HB) produced by Merck. The new product is distinguished from the original by an orange streak on the label stating "Preservative Free". Use of the new product should be limited to infants at this time in order to assure sufficient supplies for all children. MMWR 1999;48(35):780-2. (08-27-99)
    Link

  • Hepatitis B Vaccine and Multiple Sclerosis: 
    A statement prepared by Neal Halsey, MD responding to the issue of Hepatitis B Vaccine and Multiple Sclerosis. (8-30-99)
    More Info

  • Suspension of Hepatitis B Vaccine in France:  Findings of a meeting in Geneva, Sept 28-30, 1998

  • Links to other sites for information on Hepatitis B Vaccine

 

This page was last updated on February 12, 2014

© 2014 Institute for Vaccine Safety